Cee Vee Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.35 M
- Revenue Growth 49.26%
- Profit Growth 31.45%
- Ebitda -17.68%
- Net Worth 36.12%
- Total Assets -6.18%
About Cee Vee Diagnostics
Cee Vee Diagnostics Private Limited (CVDPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 April 2018 (Six years and ten months 9 days old ). Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.35 M.
Chiranjeet Varma, Mani Verma, Shobhana Verma, and One other member serve as directors at the Company.
Company Details
-
Location
Varanasi, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2018PTC102952
-
Company No.
102952
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Apr 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Cee Vee Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mani Verma
|
Director | 09-Apr-2018 | Current |
|
Chiranjeet Varma
|
Director | 09-Apr-2018 | Current |
|
Shobhana Verma
|
Director | 21-Oct-2021 | Current |
|
Aayushmaan Verma
|
Director | 21-Oct-2021 | Current |
Financial Performance of Cee Vee Diagnostics.
Cee Vee Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.26% increase. The company also saw a substantial improvement in profitability, with a 31.45% increase in profit. The company's net worth Soared by an impressive increase of 36.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cee Vee Diagnostics?
In 2022, Cee Vee Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vkv Technologies Private LimitedMani Verma and Aayushmaan Verma are mutual person
Charges (Loans)
₹5.35 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2018 | Indian Bank | ₹5.35 M | Open |
How Many Employees Work at Cee Vee Diagnostics?
Unlock and access historical data on people associated with Cee Vee Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cee Vee Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cee Vee Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.